CMQ 6:43 PM Update to Shareholders 3 PDF http://sa.iguana2.com/cache/adccd61f398dcecdf410a581a7a899bc/ASX-CMQ-399842.pdfwrtu
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%